"The
Report Osteoarthritis Global Clinical Trials Review, H1, 2016
provides information on pricing, market analysis, shares, forecast,
and company profiles for key industry participants. -
MarketResearchReports.biz"
GlobalData's clinical trial
report, Osteoarthritis
Global Clinical Trials Review, H1, 2016"
provides an overview of Osteoarthritis clinical trials scenario. This
report provides top line data relating to the clinical trials on
Osteoarthritis. Report includes an overview of trial numbers and
their average enrollment in top countries conducted across the globe.
The report offers coverage of disease clinical trials by region,
country (G7 & E7), phase, trial status, end points status and
sponsor type. Report also provides prominent drugs for in-progress
trials (based on number of ongoing trials). GlobalData Clinical Trial
Reports are generated using GlobalDatas proprietary database - Pharma
eTrack Clinical trials database. Clinical trials are collated from
80+ different clinical trial registries, conferences, journals, news
etc across the globe. Clinical trials database undergoes periodic
update by dynamic process.
The report enhances the
decision making capabilities and helps to create an effective counter
strategies to gain competitive advantage.
Download
Sample copy of this Report at :
http://www.marketresearchreports.biz/sample/sample/676705
Scope
- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months
Reasons
to buy
- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level
Table
of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Report Guidance 5
Clinical Trials by Region 6
Clinical Trials and Average
Enrollment by Country 7
Top Five Countries Contributing
to Clinical Trials in Asia-Pacific 9
Top Five Countries Contributing
to Clinical Trials in Europe 10
Top Countries Contributing to
Clinical Trials in North America 11
Top Five Countries Contributing
to Clinical Trials in Middle East and Africa 12
Top Five Countries Contributing
to Clinical Trials in Central and South America 13
Clinical Trials by G7
Countries: Proportion of Osteoarthritis to Immunology Clinical Trials
14
Clinical Trials by Phase in G7
Countries 15
Clinical Trials in G7 Countries
by Trial Status 16
Clinical Trials by E7
Countries: Proportion of Osteoarthritis to Immunology Clinical Trials
17
Clinical Trials by Phase in E7
Countries 18
Clinical Trials in E7 Countries
by Trial Status 19
Clinical Trials by Phase 20
In Progress Trials by Phase 21
Clinical Trials by Trial Status
22
Clinical Trials by End Point
Status 23
Subjects Recruited Over a
Period of Time 24
Clinical Trials by Sponsor Type
25
Prominent Sponsors 26
Top Companies Participating in
Osteoarthritis Therapeutics Clinical Trials 27
Prominent Drugs 28
Latest Clinical Trials News on
Osteoarthritis 29
Jan 28, 2016: Medivir initiates
phase IIa study of MIV-711 in knee osteoarthritis 29
Jan 13, 2016: Cellular
Biomedicine Group Announces Positive 48-Week Data from Phase IIb
Clinical Trial for Knee Osteoarthritis Stem Cell ReJoin Therapy 29
Jan 06, 2016: Zynerba
Pharmaceuticals Announces Positive Initial Results From ZYN002 CBD
Gel Phase 1 Single Rising Dose Trial and Initiation of Phase 1
Multiple Rising Dose Trial 30
Jan 06, 2016: Launch of Phase I
clinical Trial for AlloJoin Off-the-Shelf Allogeneic Stem Cell
Therapy for KOA 31
Dec 22, 2015: Upcoming
Presentation to Release 48-Week Data From Phase IIb Clinical Trial
for ReJoin 31
Dec 21, 2015: Antibe
Therapeutics Announces Completion of Validation Studies of ATB-346,
Progression to Phase 2 Clinical Trials 31
Dec 09, 2015: Cara Therapeutics
Announces Positive Top-Line Results From Phase 2a Trial of Oral CR845
in Chronic Pain Patients With Osteoarthritis of the Knee or Hip 32
Dec 01, 2015: Flexion
Therapeutics Enrolls First Patient in Pharmacokinetic Study of
Zilretta for Osteoarthritis of the Knee 33
Clinical Trial Profile
Snapshots 34
Appendix 741
Abbreviations 741
Definitions 741
Research Methodology 742
Secondary Research 742
About GlobalData 743
Contact Us 743
Disclaimer 743
Follow
us on LinkedIn:
https://www.linkedin.com/company/marketresearchreports-biz
About
us
MarketResearchReports.biz
is the most comprehensive collection of market research reports.
MarketResearchReports.Biz services are specially designed to save
time and money for our clients. We are a one stop solution for all
your research needs, our main offerings are syndicated research
reports, custom research, subscription access and consulting
services. We serve all sizes and types of companies spanning across
various industries.
Contact
Mr.
Nachiket
State
Tower
90
Sate Street, Suite 700
Albany,
NY 12207
Tel:
+1-518-621-2074
No comments:
Post a Comment